Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Treatment

Bolster: Caregiver App to Reduce Duration of Untreated Psychosis

Caregiver to a Young Adult With Early Psychosis

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Change in Family Communication — 58.94; 56.66; 53.23; 53.20 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Bolster (Behavioral); Control (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Washington
Primary completion
Oct 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Family Communication
58.94; 56.66; 53.23; 53.20; 52.02; 53.55
PRIMARY
Change in Treatment Facilitation
22.47; 24.29; 18.79; 16.60; 20.08; 19.54
PRIMARY
Change in Loved One Treatment Engagement, Medication Provider
15; 8; 21; 7
PRIMARY
Change in Loved One Treatment Engagement, Therapy or Counseling
17; 8; 24; 8
SECONDARY
Change in Illness Knowledge, Factual Knowledge
15.90; 15.65; 16.16; 16.15; 16.08; 15.63
SECONDARY
Change in Illness Knowledge, Caregiver Self-rated
13.40; 11.35; 10.97; 10.96; 10.92; 10.58
SECONDARY
Change in Illness Appraisals, Consequences
79.63; 80.90; 76.13; 79.77; 75.93; 80.39
SECONDARY
Change in Illness Appraisals, Control
30.06; 31.70; 30.65; 31.80; 31.46; 31.63
SECONDARY
Change in Illness Appraisals, Emotional Distress About Illness
34.74; 31.85; 30.63; 32.55; 29.64; 32.11
SECONDARY
Change in Appraisal of Caregiving Experiences**
43.04; 45.77; 40.11; 42.70; 37.94; 42.76
SECONDARY
Change in Caregiver Coping, Activities
35.32; 37.25; 36.07; 34.72; 36.81; 36.84
SECONDARY
Change in Caregiver Coping, Self-efficacy
135.23; 142.23; 154.86; 149.25; 168.99; 160.84
SECONDARY
Change in Caregiver Distress
19.00; 18.45; 14.14; 17.75; 11.67; 15.68

Summary

The proposed research project aims to develop and test a mobile health intervention designed to improve caregivers' illness knowledge and caregiving skills through interactive cognitive-behavioral modules, and through these improvements, reduce distress, improve coping, improve family communication, increase caregiver treatment facilitation and reduce duration of untreated psychosis. This clinical trial will involve a remote pilot randomized controlled trial comparing this new intervention to existing online caregiving support resources. Analyses will determine whether this approach is acceptable and feasible, as well as explore its effectiveness and impact on key components of the cognitive model of caregiving.

Eligibility Criteria

Inclusion Criteria

  • 18 years old or older
  • Live in the United States
  • Caregiver to a young adult with early psychosis, wherein early psychosis is defined as: (1) Being between the ages of 15 and 35, and (2) Within the past five years, the young adult first experienced: (2A) Presence of psychotic symptoms represented by one or more of hallucinations, delusions, marked thought disorder, psychomotor disorder or bizarre behavior, as well as (2B) Definite change of personality or behavior manifesting as two or more of the following: serious deterioration of function, marked social withdrawal, persistent self-neglect, episodic marked anxiety.
  • A positive screen according to the Caregiver Prime Screen - Revised (endorsed two or more responses of five or six ("somewhat"/"definitely" agree))
  • Own an Apple iPhone
  • Self-identify as a caregiver of the affected person
  • The affected person is not enrolled in specialty mental health services (i.e. a program wherein the affected person can access psychiatry and counseling/therapy services), and has not been enrolled in such services for at least three months prior to screening. If an affected person is receiving one of these services, the caregiver reports that this is an inadequate level of care.

Exclusion Criteria

  • Incarceration or long-term care setting for either the caregiver or identified affected young adult.
  • Participant failed to demonstrate understanding of study details in comprehension screening process.
  • The affected person is unengaged in services, but only as a result of having completed or "graduated" from a specialty treatment program for psychosis.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04949542). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search